Archive: 28/01/2022
Merck says Covid pill 'active' against Omicron
Merck's anti-COVID pill remains "active" against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
Jan 28, 2022
Merck's anti-COVID pill remains "active" against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
Jan 28, 2022